Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
72 hedge funds and large institutions have $33.3M invested in Avid Bioservices, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 10 closing their positions.
88% more call options, than puts
Call options by funds: $762K | Put options by funds: $406K
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
20% more capital invested
Capital invested by funds: $27.8M → $33.3M (+$5.44M)
4% more funds holding
Funds holding: 69 → 72 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.78M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.22M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.02M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$602K |
| 5 |
State Street
Boston,
Massachusetts
|
+$300K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$558K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$385K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$362K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$349K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$341K |
CDMO Hedge Fund Activity: Q3 2013 in Review
72 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2013, worth a combined $33.3M — up 20% from $27.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CDMO positions and 10 closed out — a net gain of 4 holders — while 28 added to existing stakes and 16 trimmed.
The largest buyer was Northern Trust, adding an estimated $1.78M. The largest seller was Goldman Sachs, cutting an estimated $558K.
- 72 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2013, up from 69 in Q2 2013.
- Funds reported $33.3M of Avid Bioservices, Inc. Common Stock stock for Q3 2013, up 20% quarter-over-quarter.
- 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2013 and 10 closed out, a net change of +4 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2013 was Northern Trust, an estimated $1.78M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2013 was Goldman Sachs, an estimated $558K sold.
Based on aggregated 13F filings for Q3 2013.